Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,204 | -1,983 | -7,013 | -4,339 | -2,376 |
| Depreciation Amortization | 36 | 18 | 75 | 55 | 37 |
| Other Working Capital | -561 | -108 | 675 | 154 | 9 |
| Other Operating Activity | 63 | 172 | -812 | -982 | -1,210 |
| Operating Cash Flow | $-3,666 | $-1,901 | $-7,075 | $-5,111 | $-3,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -25 | -25 | N/A |
| Net Acquisitions | N/A | N/A | 1,450 | 1,250 | 1,250 |
| Other Investing Activity | 0 | 0 | 250 | 450 | 0 |
| Investing Cash Flow | $N/A | $N/A | $1,675 | $1,675 | $1,250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,400 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | N/A | 2,640 | 2,640 | 2,640 |
| Other Financing Activity | -726 | -5 | 1,811 | 872 | -78 |
| Financing Cash Flow | $1,674 | $-5 | $4,452 | $3,512 | $2,562 |
| Beginning Cash Position | 4,081 | 4,081 | 5,083 | 5,083 | 5,083 |
| End Cash Position | 2,089 | 2,175 | 4,081 | 5,117 | 5,457 |
| Net Cash Flow | $-1,992 | $-1,905 | $-1,003 | $33 | $374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,666 | -1,901 | -7,075 | -5,111 | -3,540 |
| Capital Expenditure | N/A | N/A | -27 | -27 | N/A |
| Free Cash Flow | -3,666 | -1,901 | -7,102 | -5,138 | -3,540 |